Gara Jalqabaatti › Lymphoma B-Cell
Qorannoo klinikaalii Lymphoma B-Cell Ameerikaa Keessatti hirmaatuu
Qorannoo 67 Lymphoma B-Cell f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 18
- Houston, TXQorannoo 16
- Chicago, ILQorannoo 13
- Nashville, TNQorannoo 11
- Philadelphia, PAQorannoo 11
- Rochester, MNQorannoo 10
- Milwaukee, WIQorannoo 9
- Baldwin Park, CAQorannoo 9
- Cleveland, OHQorannoo 9
- Boston, MAQorannoo 8
- Salt Lake City, UTQorannoo 8
- Washington, DCQorannoo 7
- Pittsburgh, PAQorannoo 7
- Columbus, OHQorannoo 7
- Charlotte, NCQorannoo 7
- Denver, COQorannoo 7
- Seattle, WAQorannoo 7
- Dallas, TXQorannoo 7
- Aurora, COQorannoo 7
- San Antonio, TXQorannoo 6
- New Haven, CTQorannoo 6
- Atlanta, GAQorannoo 6
- Los Angeles, CAQorannoo 6
- Edison, NJQorannoo 6
- Mountain View, CAQorannoo 5
- Portland, ORQorannoo 5
- Ann Arbor, MIQorannoo 5
- St. Louis, MOQorannoo 5
- Kansas City, MOQorannoo 5
- Omaha, NEQorannoo 5
- Cincinnati, OHQorannoo 5
- Richmond, VAQorannoo 4
- Tampa, FLQorannoo 4
- Miami, FLQorannoo 4
- Louisville, KYQorannoo 4
- Winston-Salem, NCQorannoo 4
- Cedar Rapids, IAQorannoo 4
- Jacksonville, FLQorannoo 4
- Indianapolis, INQorannoo 4
- Austin, TXQorannoo 3
Naannoon
- ArizonaQorannoo 5
- CaliforniaQorannoo 20
- ColoradoQorannoo 12
- ConnecticutQorannoo 6
- Distaarikii KoloombiyaaQorannoo 3
- FloridaQorannoo 15
- GeorgiaQorannoo 8
- IllinoisQorannoo 13
- IndianaQorannoo 5
- IowaQorannoo 6
- KansasQorannoo 9
- KentuckyQorannoo 4
- MarylandQorannoo 7
- MassachusettsQorannoo 8
- MichiganQorannoo 7
- MinnesotaQorannoo 12
- MissouriQorannoo 5
- NebraskaQorannoo 5
- New JerseyQorannoo 9
- New YorkQorannoo 20
- North CarolinaQorannoo 11
- OhioQorannoo 18
- OregonQorannoo 6
- PennsylvaniaQorannoo 16
- TennesseeQorannoo 13
- TexasQorannoo 26
- UtahQorannoo 8
- VirginiaQorannoo 8
- WashingtonQorannoo 10
- WisconsinQorannoo 10
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 18 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06173518Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06343311CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05442515A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07439653A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06350318Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06052826A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06213311A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05615636UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Namoota walitti qabaa jiraSadarkaa 1/2
31 Days – 30 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT04544592Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05272384Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06393738Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 4 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07652580Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07516093A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07123454Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07520006A Study of ARC-02 in B-cell NHL
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05389423Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.